MediciNova Inc. (MNOV) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MediciNova Inc.

    NASDAQ: MNOV · Real-Time Price · USD
    1.29
    -0.05 (-4.03%)
    At close: Sep 05, 2025, 3:59 PM
    1.29
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    MediciNova Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 1M n/a 4.04M
    Cost of Revenue
    		 21.08K n/a 212.43K n/a
    Gross Profit
    		 -21.08K 1M -212.43K 4.04M
    Operating Income
    		 -12.68M -9.9M -14.63M -10.22M
    Interest Income
    		 1.67M 1.83M 809.67K 143.63K
    Pretax Income
    		 -11.04M -8.57M -14.07M -10.13M
    Net Income
    		 -11.05M -8.57M -14.07M -10.13M
    Selling & General & Admin
    		 5.48M 5.24M 5.48M 5.72M
    Research & Development
    		 7.17M 5.66M 9.14M 8.54M
    Other Expenses
    		 n/a n/a -247.28K -59.5K
    Operating Expenses
    		 12.65M 10.9M 14.63M 14.25M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 258.65K 257.93K n/a n/a
    Cost & Expenses
    		 -12.68M 10.9M 14.63M 14.25M
    Income Tax Expense
    		 5.54K 3.05K 2.82K 2.57K
    Shares Outstanding (Basic)
    		 49.05M 49.05M 49.05M 48.6M
    Shares Outstanding (Diluted)
    		 49.05M 49.05M 49.05M 48.6M
    EPS (Basic)
    		 -0.23 -0.17 -0.29 -0.21
    EPS (Diluted)
    		 -0.23 -0.17 -0.29 -0.21
    EBITDA
    		 -11.02M -9.88M -13.85M -10.19M
    EBIT
    		 -11.04M -9.9M -14.63M -10.22M
    Depreciation & Amortization
    		 21.08K 20.3K 212.43K 26.15K

    Add to Watchlist